About - Hospitals - Programs and Services - Outpatient - Locations - Giving
Conemaugh Memorial Chosen to Participate in International ISCHEMIA Study
Home > About Us > Media Center > Press Releases > Conemaugh Memorial Chosen to Participate in International ISCHEMIA Study

Posted: 2013-01-28


Dr. Robert Stenberg

Dr. Roshan Patel


A research study underway at Conemaugh Memorial Medical Center will compare the effectiveness of Medical and Invasive treatments for Ischemia – a condition caused by heart arteries becoming narrowed due to a buildup of cholesterol plaque.

The ISCHEMIA study – the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches, will involve around 8,000 people at over 500 medical facilities around the world, including Conemaugh Memorial. The study is sponsored by the National Heart, Lung and Blood Institute (NHLBI) and is the first of its kind.

The goal of the study is to compare two routine treatments used by doctors around the world to treat narrowed heart arteries. Volunteers for the study will be assigned to receive medications and lifestyle counseling alone, or receive a procedure to see whether coronary stents or bypass surgery is needed in addition to medicines and lifestyle counseling. The study will compare the two treatments to determine which option saves more lives and prevents more heart attacks.

“This will be a very important, high impact study in the world of cardiovascular medicine,” says Dr. Robert Stenberg, Interventional Cardiologist at Conemaugh Memorial Medical Center. “There is expected to be an impact on public health as a result of this study. It’s an honor for Conemaugh Memorial Medical Center to be included as a participating center in such a prestigious trial.” Dr. Stenberg will lead the study at Conemaugh Memorial.

Sub-investigator Dr. Roshan Patel, Conemaugh Physician Group – Cardiology is excited for the medical conclusions this trial may bring. “The information obtained from this study will be very important to guide treatment decisions for our cardiovascular patients,” he says.

Ischemic heart disease (IHD) is the leading cause of death and disability worldwide. Ischemic heart disease affects 17,600,000 Americans, resulting in about 450,000 deaths in the United States each year. Globally, 7.2 million deaths are caused by IHD each year.

Additional medical centers participating within the United States include Albany Stratton VA Medical Center, Harvard University, Emory University and Cedars-Sinai Medical Center to name a few. Conemaugh Memorial Medical Center joins the elite group of research institutions as one of only a few community-based hospitals to participate in this study.


About the Conemaugh Health System
Serving over a half-million patients each year through the Conemaugh Physician Group and Medical Staff, a network of hospitals, specialty clinics and patient focused programs; Conemaugh Health System (CHS) is the largest healthcare provider in West Central Pennsylvania with 4,500+ employees and 350 physicians. Conemaugh Health System (CHS) has been named an IMS Top 100 Integrated HealthCare Network for 2012.

About NYU Langone Medical Center
NYU Langone Medical Center, a world-class, patient-centered, integrated, academic medical center, is one of the nation’s premier centers for excellence in clinical care, biomedical research and medical education. Located in the heart of Manhattan, NU Langone is composed of three hospitals - Tisch Hospital, Rusk Insitute of Rehabilitation Medicine and the Hospital for Joint Diseases. For more information, visit www.NYULMC.org.

For More Information, Please Contact:
Amy Bradley, Director of Public Affairs
Phone: (814) 534-3121
Email: abradle@conemaugh.org